Approximately one-third of patients with systemic lupus erythematosus (SLE) admit to self-managing their corticosteroid medication without the consent of their rheumatologist or healthcare provider (HCP). The findings, which stem from the multi-country GSK suvey called EnABLE, highlight the need for a more proactive approach in lupus management, and improved awareness…
The University of Alabama at Birmingham (UAB) has received a one-year, $250,000 grant from the Lupus Research Alliance to investigate how lupus develops and why some people are at greater risk for flare-ups and kidney disease. While no one knows exactly why lupus develops, researchers think a…
Environmental factors, including UV light and air pollution, can significantly contribute to the development or progression of systemic lupus erythematosus (SLE), according to a new review. The review, titled “Environmental triggers in systemic lupus erythematosus,” was led by Dr. Gaurav Gulati, MD, a physician-researcher at the University…
Patients with systemic lupus erythematosus (SLE) show significantly higher rates for dementia compared to healthy people, according to a large cross-sectional Israeli study. The research, “High proportions of dementia among SLE patients: A big data analysis,” was published in the journal International Journal of Geriatric Psychiatry. Lupus…
Patients with more severe damage caused by systemic lupus erythematosus spend four times as much on healthcare than those with the lowest levels of lupus damage, Canadian researchers said at a recent scientific meeting. The findings underscore the importance of using more effective therapies in early disease stages, lowering costs…
Progentec Diagnostics is closer to marketing a new set of tools for predicting lupus flares after obtaining $1.25 million in financing. The Oklahoma Medical Research Foundation created the technology the company is using. Progentec is collaborating with Dr. Judith James, a lupus researcher who developed the technology, to refine the platform.
Patients with lupus found the Patient Reported Outcomes Measurement Information System (PROMIS) assessment tool to be relevant, valuable, and useful in improving clinical care, according to a new study. Results from the study, which was conducted at the Hospital for Special Surgery (HSS) in New York, was presented at the…
The Lupus Foundation of America and EMD Serono have teamed up to advance a global initiative aimed at identifying critical treatment gaps and finding solutions for them. The ALPHA Project’s goal is to improve lupus care. ALPHA stands for Addressing Lupus Pillars for Health Advancement. There are two parts to the initiative.
Cellenkos announced a new collaboration with The University of Texas MD Anderson Cancer Center to develop cord blood regulatory T-cell (CB TREG) therapeutics for autoimmune diseases and inflammatory disorders such as lupus. The company will fund up to $10 million for the CB TREG program over five years. Led by Simrit Parmar…
The rate of cardiovascular events in lupus patients increased during the second half of a 15-year period, a long-term study found. Cardiovascular events included angina (chest pain), fatal or nonfatal acute myocardial infarction (MI), transient ischemic attack (“mini-stroke”), fatal and nonfatal stroke, and cardiovascular (CV) death. The study, titled “…